S'abonner

Risk-adjusted sequential probability ratio test control chart methods for monitoring operator and institutional mortality rates in interventional cardiology - 09/08/11

Doi : 10.1016/j.ahj.2007.08.022 
Michael E. Matheny, MD, MS, MPH a, b, d, , Lucila Ohno-Machado, MD, PhD a, d, Frederic S. Resnic, MD, MS a, c, d
a Decision Systems Group, Department of Radiology, Brigham and Women's Hospital, MA 
b Division of General Medicine, Brigham and Women's Hospital, Boston, MA 
c Division of Cardiology, Brigham and Women's Hospital, Boston, MA 
d Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 

Reprint requests: Michael E. Matheny, MD, MS, MPH, Division of General Internal Medicine and Public Health, Vanderbilt University, Suite 6000, Medical Center East North Tower, 1215 Twenty-first Avenue South, Nashville, TN 37232-8300.

Résumé

Background

The objective of this study was to evaluate risk-adjusted sequential probability ratio test control charts for the detection of significant discrepancies between institution or individual interventional cardiologist postprocedural mortality rates and national or local event rate expectations.

Methods

Eight thousand nine hundred forty-two percutaneous coronary interventional procedures were performed by 27 operators between January 1, 2002, and November 30, 2006. The institution-based evaluation included all procedures, and the individual-based evaluations included 8750 procedures performed by 18 operators who had each done at least 100 PCI procedures. Risk-adjusted sequential probability ratio test control charts were developed to assess whether the odds ratios (ORs) for death were >2.0 for α = β = 0.10. The American College of Cardiology 1.1 prediction model was used to risk-adjust both the institution and individuals, and an additional local model was used for individuals.

Results

After national risk adjustment, the local institution did not show mortality of more than a 1.5 OR. Two operators had a >2.0 mortality OR after national risk adjustment, and one of those remained elevated after local risk adjustment. Of 18 operators, 10 had insufficient data to allow us to accept or reject the hypothesis of increased risk.

Conclusions

The local institution performed within national expectations, but 1 operator was identified as having poor performance, which prompted an in-depth review of that operator's cases. The review revealed that the operator had an unusually high number of patients who presented with risk factors not included in the risk-adjustment models. This study highlights the utility of risk-adjusted sequential probability ratio test as a method for outcomes monitoring and quality control in interventional cardiology.

Le texte complet de cet article est disponible en PDF.

Plan


 This research was supported in part by grants 1-T15-LM-07092 and R01-LM-08142-04 from the National Library of Medicine, Bethesda, MD of the National Institutes of Health, Bethesda, MD. The authors have no conflict of interests to disclose.


© 2008  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 155 - N° 1

P. null - janvier 2008 Retour au numéro
Article précédent Article précédent
  • A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE)
  • Ik-Kyung Jang, Neil J. Weissman, Michael H. Picard, Michael R. Zile, Veronica Pettigrew, Steven Shen, Jun Tatsuno, Mark G. Hibberd, Dan Tzivoni, Frans J. Th. Wackers, the EVOLVE Investigators
| Article suivant Article suivant
  • Guideline adjudicated fibrinolytic failure: Incidence, findings, and management in a contemporary clinical trial
  • Christopher E. Buller, Robert C. Welsh, Cynthia M. Westerhout, John G. Webb, Blair O'Neill, Richard Gallo, Paul W. Armstrong

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.